SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma
Status:
Unknown status
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to elucidate whether SentoClone® gives improved treatment
responses in patients with advanced malignant melanoma in comparison to established reference
treatment(s).